The US FDA has approved CSL's HEMGENIX (etranacogene dezaparvovec-drlb) as the first and only one-time gene therapy for appropriate adults with haemophilia B. …
CSL secures US approval for breakthrough one-time haemophilia gene therapy
November 24, 2022 Latest NewsBioPharma
Latest Video
New Stories
-
The Week in Review Podcast - 3 May
May 3, 2024 - - Podcast -
New data shows significant increase in the number of pharmacies supplying naloxone
May 3, 2024 - - Latest News -
CSL Seqirus secures local rights to new adrenaline nasal spray
May 3, 2024 - - Latest News -
Industry applauds funding commitment for National One Stop Shop for clinical trials
May 3, 2024 - - Latest News -
Access should not be redefined as including access via a clinical trial
May 3, 2024 - - Latest News -
Another reform process fails - how many times does this need to happen?
May 2, 2024 - - Latest News -
New coalition established to advocate for action on radiation therapy
May 2, 2024 - - Latest News